What is DIPG?

Diffuse intrinsic pontine glioma (DIPG) is a cancer of the pons – the area of the brain directly above the brainstem – and is considered one of the most dreaded forms of childhood cancer due to the historically poor prognosis. DIPG is very rare and affects approximately 300 children per year in the United States. There is no known cause; it affects girls and boys equally; spans all social, racial and religious groups; and has a peak incidence around 6 to 9 years of age.

Cancerous tumors are classified and named based on their pathology and location. This tumor is diffusely spread throughout the pons and initially forms in the glial cells of the brain. DIPG is also called diffuse pontine glioma, diffusely infiltrative brainstem glioma, and brainstem glioma. The MJ Foundation and most of the organizations that we collaborate with use the name diffuse intrinsic pontine glioma (DIPG).

Having your child diagnosed with DIPG is earth shattering. Everything in your life becomes reprioritized. When it comes to the health of your child, you know them better than anyone else in the world including your doctor. Trust your judgment, ask questions and don’t be afraid to seek second opinions.

Prognosis

Survival times vary from child to child with the majority of children dying within one year of diagnosis. Fewer than ten percent of children survive for more than two years.

Treatment

Treatment plans for DIPG are usually designed to relieve the symptoms of the cancer as well as reduce the size and growth rate of the tumor.

Radiation or Radiotherapy

Radiation is the primary treatment plan for most children as it has shown positive results in reducing the size of tumor. Radiation therapy is given in low doses over approximately six weeks to the exact portion of the brain that is affected. The first few sessions are used to create a targeting mask for the treatments and will include another CAT scan or MRI. Your child will wear the mask during subsequent treatments to ensure that the radiation is being delivered to the correct portion of the brain to maximize the effectiveness. Common side effects of radiation include decreased energy and hair loss to the radiated areas.

Chemotherapy

Chemotherapy and other cancer fighting drugs are constantly being evaluated for use in treating DIPG. Traditionally, chemotherapy has shown little impact on the treatment of DIPG due to the blood brain barrier that protects the brain from infections. Improvements have been made in recent years, but to date there is no commonly accepted chemotherapy plan for DIPG. Many of these newer treatment plans are designed to increase the effectiveness of radiation therapy. Your doctor will present you with information on any of these programs that are currently available. We recommend asking your doctor for details on how clinical trials are designed and operated as well as for details on the side effects of the treatment, how the drugs are administered, and what the expected outcomes are.

Steroids

Decadron (Dexamethasone) is a very powerful steroid commonly prescribed to reduce the swelling of the tumor and relieve many of the initial symptoms associated with DIPG. Most children are slowly weaned off if it during or after radiation. Many doctors prescribe it as part of palliative care as well due to the speed at which it can relieve swelling and the accompanying symptoms. Side effects include decreased energy, sleeplessness, irritable mood changes, food cravings, weight gain, puffiness of the face, high blood pressure, and an increased risk of infection. We recommend patience and love when dealing with your child while they are taking Decadron.

Neurosurgery

Surgery is not a common option for DIPG due to the way that the cancer diffusely grows between the normal cells of brain. Surgery can be used to place shunts into the brain to relieve pressure, but this is uncommon.